Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2026-05-17 @ 12:36 PM
Study NCT ID:
NCT04610658
Status:
TERMINATED
Last Update Posted:
2024-04-02
First Post:
2020-10-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC
Sponsor:
Organization: